Posted on July 17, 2018
By Spyros Papapetropoulos, MD, PhD Chief Medical Officer Cavion, Inc. Collaboration with the International Essential Tremor Foundation (IETF) is critical for advancing new treatment approaches for essential tremor (ET). Our company, Cavion Inc., has been engaged in the discovery and development of a new class of T-type calcium channel (Cav3) inhibitors for the treatment of […]
Categories: Research Study